New officers named to office-based lab section

Mar 01, 2021 Re-posted from the March 2021 issue of Vascular Specialist

By Beth Bales

New officers are in place with the SVS Section on Outpatient and Office Vascular Care (SOOVC) Executive Committee.

New officers are in place with the SVS section on SOOVC Executive Committee. They are Robert Molnar, MD, chair; Clifford Sales, MD, vice chair; and members Ruosu An, MD, Ellen Derrick, MD, Anil Hingorani, MD, Jacqueline Majors, MD, and Bradley Thomas, MD.

SVS created the section in 2019 for clinicians who work in outpatient and office based vascular care centers. It serves as a forum where members can advance the care of patients in outpatient settings through enhancing SVS efforts in education, advocacy, quality practice, ethics and research.

Activities have included a special breakfast section on outpatient facilities at the 2019 Vascular Annual Meeting and a question-and-answer session on SVSConnect.

All SVS members in good standing who are interested in outpatient and office vascular care may apply for membership in the section. Hospital and practice administrators may join as Affiliate members. Email soovc@vascularsociety.org

Tags
Vascular Specialist

Related Articles

Education and Representation at the Core of Inclusivity Efforts for DEI Committe

This article was published in the October issue of Vascular Specialist.

The Society for Vascular Surgery’s (SVS) Diversity, Equity, and Inclusion (DEI) Committee continues to make strides in advancing inclusivity within the organization, with several projects underway to address both ongoing challenges and new opportunities.

Why donate to the SVS PAC?

A few years ago, in his presidential address to the Midwestern Vascular Surgical Society, Mark Mattos, MD, spoke eloquently about the need to “protect our specialty.” A large part of this, he argued, is protecting our patients; no other specialty in medicine can provide the type of comprehensive vascular care that we offer. The daily reality we all face is the potential for declining Medicare reimbursement for our services.

Progress made during year like no other

While the COVID-19 pandemic and its effects dominated 2020–21 fiscal year—including the cancellation of the live 2020 Vascular Annual Meeting (VAM)—it did not deter progress on many important initiatives. “When covid hit, it intensified our focus on what was truly important: our members, their patients and the SVS as their Society,” said Executive Director Kenneth M. Slaw, PhD. “That focus was sustained the past 15 months and it has led to innovation and an unprecedented volume of member value programs.” He outlined important highlights from the fiscal year that ended March 31—just more than a year after the pandemic was declared—and the vital initiatives that continue to move forward.